Search results

Scientific presentations 2018: European HD Network (EHDN) Plenary meeting in Vienna, Austria. Poster presentation 2011-2014: The National Huntington’s Disease meeting, Gothenburg, Sweden. Oral presentation 2014: Hereditary disease foundation: The Milton Wexler Celebration of Life, Boston, USA. Poster presentation 2014: European HD Network (EHDN) Plenary meeting in Barcelona, Spain. Poster presenta

https://www.huntington-research.lu.se/scientific-presentations-sanaz-gabery - 2026-07-17

Awards2016: Lund University, EMV neurobiology section best PhD thesis award of 2016; Hypothalamic and Metabolic Dysfunction in Genetic Models of Huntington's Disease.2017: Hjärnfonden Postdoctoral FellowshipGrants2018: Project grant from The Royal Physiographic Society of Lund2017: Project grant from Hjärnfonden (co-applicant)2017: Project grant from Thorsten and Elsa Segerfalk Foundation2017: Pro

https://www.huntington-research.lu.se/awards-and-grants-rana-soylu-kucharz - 2026-07-17

Oral presentations2011: BAGADILICO retreat, Båstad, Sweden. Assessment of cellular specific hypothalamic dysfunction in HD.2012: NECTAR, Lund, Sweden. Effects of deletion of mutant huntingtin expression in Sim1 neurons in the BACHD mouse model of Huntington’s disease.2013: Gordon Research Conferences, CAG Triplet Repeat Disorders (GRS), Waterville Valley, USA. Long-term metabolic effects of huntin

https://www.huntington-research.lu.se/scientific-presentations-rana-soylu-kucharz - 2026-07-17

Follin C1, Fjalldal S1, Svärd D2,3, van Westen D2,3, Gabery S4, Petersén Å4, Lätt J3, Rylander L5 and Erfurth EM1.1. Department of Endocrinology, Skåne University Hospital, Lund, Sweden.2. Clinical Sciences Lund, Diagnostic Radiology, Lund University, Lund, Sweden.3. Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden.4. Translational Neuroendocrine Research Unit, Department of

https://www.huntington-research.lu.se/microstructure-alterations-hypothalamus-cranially-radiated-childhood-leukaemia-survivors-not - 2026-07-17

Kirik D1, Cederfjäll E1, Halliday G2 and Petersén Å3.1Brain Repair and Imaging in Neural Systems (B.R.A.I.N.S) Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.2Faculty of Medicine, University of New South Wales and Neuroscience Research Australia, Sydney, Australia.3Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund Universi

https://www.huntington-research.lu.se/gene-therapy-parkinsons-disease-disease-modification-gdnf-family-ligands - 2026-07-17

In connection to the Nordic Huntington Disease Research Meeting taking place in Lund, Sweden, on November 26 2019, we collect and process personal data in order to fulfill our task as the organizing body. The information we collect and process is the following: Name, title, affiliation, e-mail address and food preference, if necessary. The food preference is merely to ensure serving safe meals for

https://www.huntington-research.lu.se/personal-data-and-data-protection - 2026-07-17

Soylu-Kucharz R, Baldo B and Petersén Å.Scientific Reports Jun 23;6:28322 (2016)AbstractHypothalamic pathology, metabolic dysfunction and psychiatric symptoms are part of Huntington disease (HD), which is caused by an expanded CAG repeat in the huntingtin (HTT) gene. Inactivation of mutant HTT selectively in the hypothalamus prevents the development of metabolic dysfunction and depressive-like beh

https://www.huntington-research.lu.se/metabolic-and-behavioral-effects-mutant-huntingtin-deletion-sim1-neurons-bachd-mouse-model - 2026-07-17

Grants and Scholarships 2020: Neuroförbundet, Research grant 2020: Kungliga Fysiografiska Sällskapet i Lund, Research grant 2018: Anna Lisa Rosenberg Foundation, Research grant2018: Kungliga Fysiografiska Sällskapet i Lund, Research grant 2018: Hjärnfonden, Research grant 2017: Fredrik O Ingrid Thurings Foundation, Research grant2017: Neuroförbundet, Research grant 2017: Åhlén Foundation, Research

https://www.huntington-research.lu.se/awards-and-grants-rachel-cheong - 2026-07-17

Oral presentations Cheong RY, Hult Lundh S, Kirik D, Petersén Å. The psychiatric and metabolic phenotype of the BACHD mouse model of Huntington disease. 8th Plenary Meeting of EHDN, 2014, Spain. (Data blitz)Cheong RY, Ábrahám IM, Herbison AE. The estrogen receptor beta conundrum: A role in GnRH neurons? New Zealand Medical Science Congress, Aug 2011, Queenstown, New Zealand.Cheong RY, Kwakowsky A,

https://www.huntington-research.lu.se/scientific-presentations-rachel-cheong - 2026-07-17

Wagner L1,2,3, Björkqvist M4,5, Hult Lundh S5, Wolf R6,2, Börgel A2,7, Schlenzig D2, Ludwig HH5, Rahfeld JU2, Leavitt B7, Demuth HU2, Petersén Å4 and von Hörsten S8.Journal of Neurochemistry 137(5): 820-37 (2016)1Deutschsprachige Selbsthilfegruppe für Alkaptonurie (DSAKU) e.V, Stuttgart, Germany.2probiodrug AG, Halle (Saale, Germany.3Department of Experimental Therapy, Franz-Penzoldt-Center, Fried

https://www.huntington-research.lu.se/neuropeptide-y-npy-cerebrospinal-fluid-patients-huntingtons-disease-increased-npy-levels-and - 2026-07-17

Cheong RY, Gabery S and Petersén Å.Journal of Huntington's disease 8 (4): 375-391 (2019)AbstractHuntington's disease (HD) is a fatal genetic neurodegenerative disorder. It has mainly been considered a movement disorder with cognitive symptoms and these features have been associated with pathology of the striatum and cerebral cortex. Importantly, individuals with the mutant huntingtin gene suffer f

https://www.huntington-research.lu.se/role-hypothalamic-pathology-non-motor-features-huntingtons-disease - 2026-07-17

Petersén Å and Weydt P. Handbook of Clinical Neurology 15: 179-189 (2019) Abstract Huntington disease (HD) is a hereditary neurodegenerative disorder caused by an expanded cytosine-adenine-guanine triplet repeat in the huntingtin gene. The current diagnosis is based on the presence of typical motor signs in combination with a positive gene test. The motor onset of the disease is usually between 30

https://www.huntington-research.lu.se/psychopharmacology-huntington-disease - 2026-07-17

Niemelä V, Petersén Å, Loutfi G, Svenningsson P and Paucar M. Läkartidningen. 2020;117:FU7H Abstract Huntington's disease is an autosomal dominant neurodegenerative disease that leads to premature death. The disease is caused by a pathological CAG triplet expansion in the huntingtin gene. The disease is most common in Western populations, with onset in middle age and causing progressive motor, cog

https://www.huntington-research.lu.se/recent-advances-huntingtons-disease - 2026-07-17

Rochel B, Domínguez D J F, Stout J, Gabery S, Churchyard A, Chua P, Egan G, Petersén A, Georgiou-Karistianis N and Poudel G R.Journal of the Neurological Sciences 364: 148-153 (2016)AbstractSubjective reports of sleep disturbance are a common feature of Huntington's disease (HD); however, there is limited research investigating the relationship between sleep with changes in brain and behaviour. Th

https://www.huntington-research.lu.se/subjective-sleep-problems-huntingtons-disease-pilot-investigation-relationship-brain-structure - 2026-07-17

Sanaz Gabery, Casper G. Salinas, Sarah J. Paulsen, Jonas Ahnfelt-Rønne, Tomas Alanentalo, Arian F. Baquero, Stephen T. Buckley, Erzsébet Farkas, Csaba Fekete, Klaus S. Frederiksen, Hans Christian C. Helms, Jacob F. Jeppesen, Linu M. John, Charles Pyke, Jane Nøhr, Tess T. Lu, Joseph Polex-Wolf, Vincent Prevot, Kirsten Raun, Lotte Simonsen, Gao Sun, Anett Szilvásy-Szabó, Hanni Willenbrock, Anna Sech

https://www.huntington-research.lu.se/semaglutide-lowers-body-weight-rodents-distributed-neural-pathways - 2026-07-17

Every year in November, the Faculty of Medicine at Lund University, together with the health care organization Region Skåne and the Eric K. Fernström Foundation, organize the Research Day in Malmö and Lund. This is an opportunity for the public to listen to researches presenting topical research. Each year has its own theme and in 2019 mental illness was the topic for the event, with talks, discus

https://www.huntington-research.lu.se/research-day-2019 - 2026-07-17

2023Knut and Alice Wallenberg Foundation has in cooperation with Åsa Petersén produced a short film about Huntington's disease and Petersén's research on HD.Link to the movie "Huntington's disease - the hunt for treatment" on YouTube (opens in a new window)The European Huntington Disease Network (EHDN) elected Åsa Petersén member of the executive committee. The EHDN is a nonprofit research network

https://www.huntington-research.lu.se/highlights - 2026-07-17

Cheong RY, Tonetto S, von Hörsten S and Petersén Å. Psychoneuroendocrinology 119, 104773 (2020) Abstract Neuropsychiatric disturbances with altered social cognition, depression and anxiety are among the most debilitating early features in the fatal neurodegenerative disorder Huntington disease (HD) which is caused by an expanded CAG repeat in the huntingtin gene. The underlying neurobiological mec

https://www.huntington-research.lu.se/imbalance-oxytocin-vasopressin-system-contributes-neuropsychiatric-phenotype-bachd-mouse-model - 2026-07-17

Follin C1, Gabery S2, Petersén Å2, Sundgren PC3, Björkman-Burtcher I3,4, Lätt J3, Mannfolk P3 and Erfurth EM1.1Department of Endocrinology, Skåne University hospital and IKVL, Lund University, Lund, Sweden.2Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.3Department of Diagnostic Radiology, Skåne University Hospital and IKVL/Lun

https://www.huntington-research.lu.se/associations-between-metabolic-risk-factors-and-hypothalamic-volume-childhood-leukemia-survivors - 2026-07-17

Fjalldal S, Rylander L, van Westen D, Holmer H, Follin C, Gabery S, Petersen Å and Erfurth E M. Clinical Endocrinology (Oxf). 94(1): 48-57 (2021) Abstract Context: White matter lesions (WML) are caused by obstruction of small cerebral vessels associated with stroke risk. Craniopharyngioma (CP) patients suffer from increased cerebrovascular mortality. Objective: To investigate the effect of reduced

https://www.huntington-research.lu.se/brain-white-matter-lesions-are-associated-reduced-hypothalamic-volume-and-cranial-radiotherapy - 2026-07-17